Blue Label Telecoms (BLT) is a company with a significant stake in Cell-C, a telecommunications provider in South Africa. The performance of Cell-C has a substantial impact on Blue Label's overall results.
Since acquiring a 45% stake in Cell-C in September 2016, Blue Label's financial performance has been closely tied to the performance of Cell-C. However, Cell-C...
Blue Label Telecoms, a company known for selling secure tokens of value such as airtime, starter packs, and electricity, has faced significant challenges, particularly due to its investment in Cell-C. Acquiring a 45% stake in Cell-C in September 2016 for R7,55 billion, Blue Label's financial performance has been closely tied to the fortunes of the mobile operator....
Blue Label Telecoms (BLT) operates in the telecommunications sector, focusing on the distribution of secure tokens of value, including airtime, starter packs, and electricity. A significant development in its corporate journey was the acquisition of a 45% stake in Cell-C in September 2016, making Cell-C's performance a pivotal factor in Blue Label's financial...
See link below for the previous analysis.
Blue Label is trading as previously forecasted.
The bounce from 235 is for wave 4 so to complete wave (C), I expect one more move down for wave 5.
Blue Label Telecoms (BLT) is a company which has interests in selling secure tokens of value - such as airtime, starter packs and electricity. It bought 45% of Cell-C in September 2016 thus its results have been substantially determined by that company's results. In April 2019, S&P Global Ratings downgraded Cell-C's debt to CCC- from CCC+ because its capital...
The telecoms look to be in for some pain in the short-term and Blue Label will unlikely to be spared.
After sharing my outlook on Vodacom and Telkom yesterday as well as MTN last week, it was time to take a deeper look into Blue Label.
Starting with the rally from the March 2020 all-time low of 152 to 750, this advance is best labelled as a three wave move (ABC)...
BLUE had a strong sell-off in August 2022 from the peak of 750 zac.
The decline to 435 zac unfolded in a clear five wave impulse pattern.
What is uncertain is whether this sell-off is wave A, implying further downside, or wave C, implying 435 zac is a significant bottom.
What matters in the short-term is after a five wave sell-off, as a minimum, price should...
Blu is due a yearly low price, 9 May 2022 is plausible but not ideal as price has retraced most of the gains since then (black arrow). A strong cycle is one where higher lows take place for longer. If Blu can go lower than black arrow it would be most ideal setup for a thrust higher to recent highs.
A double bottom on the green arrow is next best thing but would...
$JSEBLU - Bullish descending triangle pattern unfolding with some upside potential.
A confirmed support above 5.40 will further support bullish trend to 5.80
Further bullish trend support above 6.00.
Target 6.60 with potential to move higher.
Blue Label has been trending upwards in a choppy manner recently.
The MACD indicator has been providing pretty accurate trading signals in this choppy market.
Classis divergence is when price makes new higher highs but the MACD makes lower highs and is viewed as bearish.
The lesser known reverse divergence is when price makes higher lows but the MACD makes lower...
This still looks like a buy for an initial move to 900c, followed by 1150c-1200c; in the medium term.
Cup & Handle technical chart pattern in play.
#Weeklychart
JSE:BLU Closed high last week Friday, few cents away from a breakout level. It opened stronger today, breaking the resistance level, the stock is also trading at a 52 week high. Suitable for a long position.
BLU finding support at its 50dma. If price can stay above R5.65 on a closing basis i am looking for a move back to R6.15.
Trade ideas are my own and not financial advice.
- Looking for any pullbacks towards R5.25 to target initially R5.75-R6.00 zone
- A close below R5 will invalidate the trade
-- MANAGE YOUR RISK - -
Disclaimer: All ideas are my opinion and should not be taken as financial advice.
